Ventas, Inc. $VTR Shares Acquired by Ethic Inc.

Ethic Inc. lifted its stake in shares of Ventas, Inc. (NYSE:VTR) by 38.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,198 shares of the real estate investment trust’s stock after buying an additional 22,382 shares during the quarter. Ethic Inc.’s holdings in Ventas were worth $6,206,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Bridgewater Advisors Inc. boosted its holdings in Ventas by 2.0% in the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares during the period. Arbor Capital Management Inc. ADV boosted its holdings in Ventas by 0.6% in the third quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock worth $1,520,000 after purchasing an additional 137 shares during the period. True Wealth Design LLC boosted its holdings in Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 138 shares during the period. Cigna Investments Inc. New boosted its holdings in Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after purchasing an additional 142 shares during the period. Finally, Foundations Investment Advisors LLC boosted its holdings in Ventas by 3.3% in the third quarter. Foundations Investment Advisors LLC now owns 4,447 shares of the real estate investment trust’s stock worth $311,000 after purchasing an additional 144 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Stock Performance

VTR stock opened at $87.26 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The stock has a market capitalization of $42.42 billion, a price-to-earnings ratio of 158.66, a PEG ratio of 2.15 and a beta of 0.74. Ventas, Inc. has a 1 year low of $61.76 and a 1 year high of $88.50. The stock’s fifty day moving average is $84.81 and its two-hundred day moving average is $80.56.

Ventas (NYSE:VTR) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s quarterly revenue was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, research analysts predict that Ventas, Inc. will post 3.85 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on VTR. Argus set a $88.00 price objective on shares of Ventas in a report on Tuesday, February 10th. Mizuho lifted their price objective on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, March 4th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a report on Friday, March 27th. Scotiabank lifted their price objective on shares of Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Ventas in a report on Monday, February 9th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $93.50.

Insider Transactions at Ventas

In other Ventas news, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president directly owned 72,755 shares in the company, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.53% of the company’s stock.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.